Anesthesia Devices Market is estimated to be US$ 56.8 billion by 2032 with a CAGR of 10.6% over the forecast period (2022-2032) - By PMI
March 15, 2023 20:06 ET
|
PMI
Covina, March 15, 2023 (GLOBE NEWSWIRE) -- The Anesthesia Devices Market has grown rapidly in recent years, driven by an increase in the number of surgical procedures performed worldwide,...
Medical Coatings Market to be Worth $3.32 Billion by 2030- Exclusive Report by Meticulous Research®
March 15, 2023 09:35 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, March 15, 2023 (GLOBE NEWSWIRE) -- According to a new market research report, ‘Medical Coatings Market By Type (Hydrophilic, Antimicrobial, Drug-eluting, Anti-thrombogenic),...
Cognition Therapeutics Announces Development Plans for Oral CT1812 in Geographic Atrophy Secondary to Dry AMD
March 15, 2023 07:30 ET
|
Cognition Therapeutics, Inc.
NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX) announced that its Investigational New Drug (IND) application for the investigation of CT1812 for geographic...
LUMIBIRD: FY 2022 RESULTS
March 14, 2023 12:50 ET
|
Lumibird SA
Lannion, March 14, 2023 – 5:45 pm FY 2022 RESULTS A €31.3m EBITDA (-4% yoy) in a year of investment and global economic tensionsReturn to a 19% EBITDA margin (23% excluding non-recurring costs) in...
AXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical Diagnostic Assay Manufacturing
March 14, 2023 09:00 ET
|
AXIM Biotechnologies, Inc.
Leading Diagnostic Healthcare Company Announces Provisional Patent Filing on Proprietary Use of Materials for Ophthalmological Test Strip Manufacturing SAN DIEGO, CA, March 14, 2023 (GLOBE...
MeiraGTx Reports Fourth Quarter and Full Year 2022 Financial and Operational Results
March 14, 2023 08:00 ET
|
MeiraGTx
- Announced positive clinical data from AQUAx AAV-hAQP1 Phase 1 trial for treatment of Grade 2/3 Radiation-Induced Xerostomia in December 2022 - Announced positive top-line data from the MGT009...
Abeona Therapeutics Announces Update on AAV Ophthalmology Program
March 14, 2023 07:30 ET
|
Abeona Therapeutics Inc.
Advancing AAV-based gene therapy candidates toward IND studies on encouraging animal proof of concept data in Stargardt Disease, X-linked Retinoschisis (XLRS), and Autosomal Dominant Optic Atrophy...
Iridex Reports Fourth Quarter and Full Year 2022 Financial Results
March 09, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
ONL Therapeutics Closes First Tranche of $15 Million Series C Financing to Advance Lead Compound into Phase 2 Clinical Trial
March 08, 2023 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., March 08, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Viridian Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
March 08, 2023 07:00 ET
|
Viridian Therapeutics, Inc
- Positive data reported from ongoing Phase 1/2 trial evaluating low-dose VRDN-001 in patients with thyroid eye disease (TED) - - First patient enrolled in ‘THRIVE’ Phase 3 trial in patients with...